Packaging Digest is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Home>Pharma & Medical

Serialization/Unique Device Identification

Highlights
Serialization validation: Start early, says expert
Serialization validation: Start early, says expert
Jun 21, 2017
Validation is a critical step in implementing serialization programs. Planning your validation approach early on can help you establish your solution objectives and work toward minimal production downtime and cost, explains Vito Pirrera, executive...
5 ongoing challenges for UDI
5 ongoing challenges for UDI
May 23, 2017
Many of FDA’s Unique Device Identification requirements have already phased in. The labels and packages of Class III and Class II medical devices, for instance, must now bear a UDI.“But UDI is not over,” says Ardi Batmanghelidj, President and CEO...
UDI gets helping hand from serialization solutions provider
UDI gets helping hand from serialization solutions provider
Mar 08, 2017
As medical device companies work to ensure compliance with Unique Device Identification, they’re still dealing with on-going tasks such as ensuring package integrity. A vision solutions provider believes it can take on both tasks. At WestPack 2017...
Standardizing serialization data exchanges
Standardizing serialization data exchanges
Nov 04, 2016
The Open Serialization Communication Standard (Open-SCS) Group was founded last year to standardize packaging line serialization and aggregation data exchanges by developing a set of industry-wide standards. Vendors comprising the group include...
When it comes to serialization, don't overlook printing
When it comes to serialization, don't overlook printing
Oct 11, 2016
As 2017 deadlines for pharmaceutical serialization draw near, Steve Wood, president of Covectra (www.covectra.com), has seen an increase in activity. “The large pharmaceutical companies decided years ago to get started, but some smaller companies...
Load More